• Medipost will hold an extraordinary shareholders’ meeting on Oct. 29, 2026 in Seongnam, South Korea.
• Items include amendments to the articles of incorporation to reflect a co-CEO structure, including related governance updates.
• Shareholders will vote on appointing Min Ho-seong as an inside director.
• The meeting will also vote on appointing Jeong Byeong-su as an independent director to serve on the audit committee.
• A stock option grant is proposed for Min Ho-seong covering 200,000 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medipost Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261014000143), on October 14, 2026, and is solely responsible for the information contained therein.